Loading organizations...
Poplar Therapeutics has raised $140.0M across 4 funding rounds.
Poplar Therapeutics has raised $140.0M in total across 4 funding rounds.
Poplar Therapeutics has raised $140.0M in total across 4 funding rounds.
Poplar Therapeutics's investors include Dan Lyons, ArrowMark Partners, RA Capital Management, SR One, Vida Ventures, Platanus, Jill Carroll, Helen Kim.
Poplar Therapeutics has raised $140.0M across 4 funding rounds. Most recently, it raised $45.0M Series A Extension in March 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 3, 2026 | $45.0M Series A Extension | Dan Lyons | ArrowMark Partners, RA Capital Management, SR One, Vida Ventures |
| Jan 7, 2026 | $50.0M Series A | Platanus, Jill Carroll, Helen Kim | |
| Poplar Therapeutics | |||
| $45.0M Poplar Therapeutics Funding Round | Dan Lyons |